BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4272340)

  • 1. [Insulin-binding antibodies and insulin resistance (author's transl)].
    Waldhäusl W
    Wien Klin Wochenschr; 1973 Dec; 85(51):833-6. PubMed ID: 4272340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin therapy].
    Petrides P
    Munch Med Wochenschr; 1970 Jul; 112(27):1273-7. PubMed ID: 4246479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of the preparative insulin chemistry for clinical diabetology].
    Petrides P
    Dtsch Med Wochenschr; 1973 Nov; 98(47):2256-8. PubMed ID: 4271376
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of insulin-antibodies in the complications of the insulin therapy].
    Fankhauser S; Diacon C
    Helv Med Acta Suppl; 1966 May; 46():164. PubMed ID: 4255643
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathology of insulin. Clinical and experimental studies.
    Federlin K
    Monogr Endocrinol; 1971; 6():1-185. PubMed ID: 4949996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Questions of antibody formation against insulin].
    Federlin K
    Z Gesamte Inn Med; 1968 Jul; 23(14):Suppl:213-4. PubMed ID: 4236365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with monocomponent insulin treatment].
    Korp W; Levett RE
    Wien Klin Wochenschr; 1973 May; 85(18):326-30. PubMed ID: 4699490
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence of proinsulin-specific antibodies in diabetic patients.
    Kumar D; Miller LV
    Horm Metab Res; 1973 Jan; 5(1):1-3. PubMed ID: 4735948
    [No Abstract]   [Full Text] [Related]  

  • 13. [Skin reaction following cutaneous insulin injection in diabetic patients requiring insulin].
    Heller H
    Allerg Asthma (Leipz); 1970; 16(4):161-7. PubMed ID: 4257714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Highly purified insulins in the modern treatment of diabetes].
    Woenckhaus JW
    Med Klin; 1975 Sep; 70(36):1401-7. PubMed ID: 1101007
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated circulating proinsulin levels in insulin-requiring diabetic patients.
    Block MB; Mako M; Steiner DF; Rubenstein AH
    J Lab Clin Med; 1971 Nov; 78(5):811-2. PubMed ID: 5316079
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin antibody titres--observations on their course in patients with diabetes mellitus. A case report].
    Grüneklee D; Takaishi T; Daweke H
    Munch Med Wochenschr; 1970 Jul; 112(27):1287-91. PubMed ID: 4193069
    [No Abstract]   [Full Text] [Related]  

  • 17. [The place of hog insulin in treatment of diabes].
    Laurent C
    Diabete; 1969; 17(2):107-13. PubMed ID: 5408009
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect on insulin antibodies on the effect iveness of insulin in metabolism].
    Bemm VH; Lohmann D; Thomitzek W-D ; Verlohren H-D
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(2):91-6. PubMed ID: 5173538
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insulin analogs with B-chains shortened at the N-terminal end. Selective Edman degradation of the insulin B chain (author's transl)].
    Geiger R; Langner D
    Hoppe Seylers Z Physiol Chem; 1973; 354(10-11):1285-90. PubMed ID: 4807833
    [No Abstract]   [Full Text] [Related]  

  • 20. C-peptide antibodies induced by bovine insulin therapy.
    Reeves WG; Douglas CA
    Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.